Skip to main content
. 2019 Jun 6;13:934. doi: 10.3332/ecancer.2019.934

Table 2. Comparing observed survival (Kaplan–Meier) versus predicted (Model FP) biochemical failure-free progression at 3, 5 and 10 years by three prognostic groups and Gleason score of 7 (≤ 6 and 7) on 249 men treated by RP for prostate cancer.

Variable predictor 3 years 5 years 10 years
Survival
observeda
% (95% CI)
Average
survival
predictedb
Survival
observeda
% (95% CI)
Average
survival
predictedb
Survival observeda
% (95% CI)
Average survival predictedb
Prognostic
Group
A
n = 142
Gleason score 6
n = 127
100 99.99 100 99.81 97.84
(91.63–99.45)
98.81
Gleason score of 7
n = 15
100 99.60 100 99.20 NO 97.95
B
n = 53
Gleason score 6
n = 37
100 99.88 100 95.46 90.00
(47.30–98.53)
74.77
Gleason score of 7
n = 16
100 93.17 100 86.77 63.47
(42.06–78.77)
69.70
C
n = 54
Gleason score 6
n =33
96.97
(80.37–99.57)
93.65 78.79
(60.59–89.27)
77.60 19.03 (7.01–35.50) 21.81
Gleason score of 7
n = 21
38.10
(18.31–57.78)
52.87 14.29
(3.57–32.12)
28.29 4.76
(0.33–19.70)
4.60

%: percentage; CI = confidence interval; ≤ = Equal or less than; NO = not observed

a

Observed survival = Kaplan–Meier Survival

b

Predicted Survival Model FP = average proportion of mean survival for a given group determined on Flexible Parametric (FP) survival model. The FP model incorporates: age (continuous variable), prognostic group B (dummy variable), prognostic group C (dummy variable) and Gleason score of 7 (dummy variable) with one degrees of freedom for the restricted cubic spline function used for the baseline hazard rate (DF1) and also, consider the dummy variables Gleason score of 7 as variable time-dependent effect using one degree of freedom for its fit in model (DFTVC1).